These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 16825023)

  • 1. Renal disease in obesity: the need for greater attention.
    Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A
    J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Overweight and obesity--risk factors in the development and progression of renal disease].
    Sebeková K; Klassen A; Bahner U; Heidland A
    Vnitr Lek; 2004 Jul; 50(7):544-9. PubMed ID: 15323263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rimonabant as a potential new treatment for an emerging epidemic of obesity-related glomerulopathy?
    Ahmed MH
    Expert Opin Emerg Drugs; 2006 Nov; 11(4):563-5. PubMed ID: 17064218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal consequences of obesity].
    Laville M
    Nephrol Ther; 2011 Apr; 7(2):80-5. PubMed ID: 21208837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Obesity and chronic kidney disease].
    Bondar' IA; Klimontov VV; Simakova AI
    Ter Arkh; 2011; 83(6):66-70. PubMed ID: 21786579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, proteinuria and progression of renal failure.
    Praga M; Morales E
    Curr Opin Nephrol Hypertens; 2006 Sep; 15(5):481-6. PubMed ID: 16914959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
    Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and kidney disease.
    Ritz E
    Blood Purif; 2008; 26(1):59-62. PubMed ID: 18182798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal consequences of obesity.
    Naumnik B; Myśliwiec M
    Med Sci Monit; 2010 Aug; 16(8):RA163-70. PubMed ID: 20671624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural renal changes in obesity and diabetes.
    Amann K; Benz K
    Semin Nephrol; 2013 Jan; 33(1):23-33. PubMed ID: 23374891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid receptor activation in obesity hypertension.
    Nagase M; Fujita T
    Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocyte lesions in patients with obesity-related glomerulopathy.
    Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS
    Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity in renal failure--health or disease?
    Stolic R
    Med Hypotheses; 2010 Dec; 75(6):497-500. PubMed ID: 20656410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of obesity and chronic kidney disease.
    Ross WR; McGill JB
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):325-35. PubMed ID: 17045219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic nephropathy: early detection, prevention and management.
    Maher JF
    Am Fam Physician; 1992 Apr; 45(4):1661-8. PubMed ID: 1558042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.